摘要:
A holder for a telecommunications device includes a container including a side wall connected to a base. Together the side wall and base define a cavity. Side wall defines an opening of the container at an end of the side wall distal to the base. A resilient insert is disposed inside the cavity. The insert includes a bottom portion that abuts the base and a feature for releasably retaining the device inside the container. A lid is in selective locking engagement with the side wall's distal end. When in locking engagement, the lid encloses the opening of the container to retain the device inside the holder, and to muffle a sound and/or a vibration produced by the device. A locking mechanism is operatively attached to the container and/or the lid, and holds the lid and the container together when the lid is in locking engagement with the distal end.
摘要:
A system and method of providing and validating a bar-code on a lottery ticket to allow secure verification of tickets is described. Lottery ticket information comprising unique identifying information uniquely identifying the lottery ticket and validation information for use in determining a prize value associated with the lottery ticket is generated. First redundancy information is generated using the validation information and a portion of the unique identifying information. The first redundancy information used for checking the integrity of subsequently received validation information. The validation information is encrypted and second redundancy information is generated using the unique identifying information and the encrypted validation information. A first bar-code is constructed using the unique identifying information, the encrypted validation information and the second redundancy information. The first bar-code is printed on the lottery ticket and at least a part of the first bar-code is covered with scratch-off material.
摘要:
Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.
摘要:
Water vapor is introduced into an inlet air stream (16) of an engine (12), for example, by a pervaporation process through a non-porous hydrophilic membrane (18). A water reservoir (20), which can contain contaminated water, provides a vapor pressure gradient across the hydrophilic membrane (18) into the inlet air stream (16), while the rate of delivery of the water vapor to a cylinder (38-40) is self-regulated by the rate of flow of air across the membrane. The hydrophilic membrane (18) therefore also filters the water from the water reservoir (20) to an extent that pure water vapor is provided to the air inlet stream (16). Delivery of water vapor can nevertheless be controlled using a hood (26) that slides over the hydrophilic membrane to limit its exposed surface area. Alternatively, water vapor is introduced into one or more of the gas streams of a fuel cell by separating the gas stream from the wet exhaust gas stream by a hydrophilic membrane such that moisture passes across the membrane to moisten the gas stream and thereby prevent drying out of the proton exchange membrane.
摘要:
Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.
摘要:
The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1), exendin, and analogs and agonists thereof, to subjects suffering therefrom.
摘要:
A bin sweep for removal of particulate from a bin having a floor, wherein the bin sweep includes an auger operated by a power mechanism and the auger comprises one or more auger blades. The bin sweep further includes a brush disposed on a shaft that is attached to the cover of the bin sweep, wherein the brush includes bristles at least in partial contact with the bin floor during operation while the blades of the auger are not in contact with the floor.
摘要:
Methods for use of an exendin, an exendin agonist, or a modified exendin or exendin agonist having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, for lowering glucagon levels and/or suppressing glucagon secretion in a subject are provided. These methods are are useful in treating hyperglucagonemia and other conditions that would be benefited by lowering plasma glucgon or suppressing glucagon secretion.
摘要:
A system for providing loans to owners of life insurance policies who are terminally ill or aged. The system comprises a statistical module, medical module and a financial module which together operate on a preselected group of inputs to yield a line of credit offered to the policyholder. The system provides a line of credit line of credit to those insured under an insurance policy without transfer of ownership of the policy. The system determines eligibility and the line of credit for the insured. The system has an entering device for entering an insured's application data, including the insured's date of birth and the medical diagnosis of the insured, and for generating an output therefrom. The system also has a generating device for receiving the output from the entering device and for generating a function therefrom having a probability distribution describing the future life distribution of the insured and a computing device for receiving the function from the generating device and for computing the line of credit to be extended to the insured based upon the received function and financial assumptions. The owner retains ownership of the policy during his lifetime, and the insured has a line of credit extended as determined by the system.